Cancer Organizations Provide Support for Required Cancer Center Distress Screening Programs
The American Psychosocial Oncology Society (APOS) has announced recommendations to support a new criterion for cancer center accreditation. In 2015, the American College of Surgeons (ACoS) Commission on Cancer (CoC) will require cancer centers to implement screening programs for psychosocial distress as a new criterion for accreditation.
Along with APOS, the Association of Oncology Social Work (AOSW) and Oncology Nursing Society (ONS) also endorse the new CoC standard of psychosocial distress screening. “This is a landmark in our work to provide cancer care for the whole patient,” said Jimmie C. Holland, MD, founder of APOS. “This mandatory screening will help address unmet psychosocial needs throughout oncology care. Our organization exists, in part, to provide educational support to meet the new CoC standards.”
This requirement will have a vast impact on patient care. There are currently over 1,500 CoC-accredited facilities in the United States serving 70% of newly diagnosed cancer patients. “The Cancer Support Community is pleased to join APOS, AOSW, and ONS in supporting the adoption of required distress screening in cancer care,” said Kim Thiboldeaux, President and CEO of the Cancer Support Community. “Integrating routine distress screening and helping patients develop a care plan to address their social, emotional, and financial needs are essential to quality cancer care.”
Joint Statement
APOS, together with AOSW and ONS, has published a joint statement to address eight key issues that must be addressed before cancer centers can adhere to the new guidelines and provide quality patient care.
“We’re pleased that the CoC has taken this step,” said William Pirl, MD, President of APOS. “Our organizations, representing over 36,000 professionals involved in care for patients with cancer, recommend that cancer centers to explore resources to help them adopt a universal definition of distress, use validated tools for distress screening, conduct screening more than once during a patient's period of treatment, and establish a process for clear communication of results to the patient’s treatment team.”
The joint statement emphasizes that referrals for the assessment and management of distress should be considered part of a patient’s routine medical care, and presented to the patient as such. Because the risk of suicide is elevated in individuals with cancer, patients whose screens suggest suicide risk should be asked about suicidal ideation as part of their clinical evaluation.
To prepare the implementation of the screening program in 2015, APOS recommends the required psychosocial representative on the cancer committee who oversees the screening program should have training in the identification and management of distress in patients with cancer. Online training opportunities are available through APOS, AOSW, and ONS.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
